BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29097253)

  • 1. BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.
    Bucciarelli PR; Tan KS; Chudgar NP; Brandt W; Montecalvo J; Eguchi T; Liu Y; Aly R; Travis WD; Adusumilli PS; Jones DR
    J Thorac Oncol; 2018 Jan; 13(1):73-84. PubMed ID: 29097253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma.
    He X; Zhou T; Yang G; Fang W; Li Z; Zhan J; Zhao Y; Cheng Z; Huang Y; Zhao H; Zhang L
    Oncotarget; 2016 Mar; 7(12):15274-87. PubMed ID: 26933815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
    Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
    Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
    Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
    J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
    Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
    Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients.
    Matsumura Y; Hishida T; Shimada Y; Ishii G; Aokage K; Yoshida J; Nagai K
    J Thorac Oncol; 2014 Mar; 9(3):337-44. PubMed ID: 24496002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors for Operated Gallbladder Cancer.
    Oven Ustaalioglu BB; Bilici A; Seker M; Kefeli U; Aydin D; Celik S; Demir T; Erkol B
    J Gastrointest Cancer; 2019 Sep; 50(3):451-457. PubMed ID: 29637517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
    Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
    Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis-related Biomarkers for Gallbladder Adenocarcinoma.
    Yang Z; Liu F; Yang ZL
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):275-82. PubMed ID: 26200836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
    Cui RX; Liu N; He QM; Li WF; Huang BJ; Sun Y; Tang LL; Chen M; Jiang N; Chen L; Yun JP; Zeng J; Guo Y; Wang HY; Ma J
    BMC Cancer; 2012 Aug; 12():376. PubMed ID: 22931099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.
    Uruga H; Bozkurtlar E; Huynh TG; Muzikansky A; Goto Y; Gomez-Caraballo M; Hata AN; Gainor JF; Mark EJ; Engelman JA; Lanuti MD; Mino-Kenudson M
    J Thorac Oncol; 2017 Mar; 12(3):458-466. PubMed ID: 27815126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of BZW2 expression in lung adenocarcinoma patients.
    Wang S; Bai W; Huang J; Lv F; Bai H
    Int J Clin Exp Pathol; 2019; 12(12):4289-4296. PubMed ID: 31933829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.
    Sun PL; Jin Y; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Virchows Arch; 2013 Sep; 463(3):427-36. PubMed ID: 23907568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
    Leeman JE; Rimner A; Montecalvo J; Hsu M; Zhang Z; von Reibnitz D; Panchoo K; Yorke E; Adusumilli PS; Travis W; Wu AJ
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):138-145. PubMed ID: 27839909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.